. 3.1.1 Shareholder structure priorto the Transaction 3.1.2 List of shareholders prior to the Transaction List of shareholders of the Target as of February 14, 2019 No. Name Number of shares Percentage of
structure, structure and proportion of shareholding shall be explained together with name list of other shareholding. The explanation, i.e., shareholding percentage and structure, other shareholders names
amount of THB. 343.72 million. This amount was deducted in shareholders' equity as part of the changes the proportion of subsidiary. Financial Position : Consolidated Balance Sheet Dec. Dec Change Dec.18
shareholders' equity as Part of the changes the proportion of subsidiary. Ratio Analysis Financial Statement year ended June 30, 2018 Return on Assets and Return on Equity in 6 months 2018 improved from 11% and
-Bearing Debt. Our Net Interest-Bearing Debt to Equity ratio was at 0.57x. PERFORMANCE BY BUSINESS Utilities Business Revenue from Sales and Services from Utilities Business in 1Q2018 of Baht 422.0 million
three months period ended 31 March 2018 and 2019 was THB 101.00 million and THB 54.04 million respectively, equivalent to a 46.50% decline. Cost of goods sold to sales revenue ratio slightly dropped from
purchase ordinary shares of Modern Pharma Company Limited ("Modern") in the proportion of 100% of the total shares from the existing shareholders with details as follows: 1. D/M/Y of the transaction The
quarter of 2018 was decreased from 26% to 22%. This is because product/service cost mix changed, with the proportion of cost of non-mobile top-up service increasing. Expenses and expenses to revenues from
quarter of 2020 increased from 19% to 22% due to the proportion of revenue of a former large customer with a low gross margin tended to continually decline. Q1’ 2020 Q1’ 2019 Increase (decrease) Million